Iopromide

Specifications

73334-07-3CAS Number

277-385-9EC Number

1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-3-N-methylbenzene-1,3-dicarboxamideIUPAC Name

C18H24I3N3O8Chemical Formula

791.1 g/molMolecular Weight

iopromide; 73334-07-3; Ultravist; Iopromidum; Iopromida; Proscope; Ultravist 300; iopromid; Ultravist 370; ZK 35760; Ultravist 150; Ultravist 240; DTXSID0023163; Ultravist (pharmacy bulk); 712BAC33MZ; ZK-35760; N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N-methylisophthalamide; DTXCID503163; CHEBI:63578; Ultravist 300 In Plastic Container; n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-n-methylisophthalamide; 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-((methoxyacetyl)amino)-N-methyl-2,4,6-triiodo-; lopromid; N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-((methoxyacetyl)amino)-N-methylisophthalamide; N-(2,3-dihydroxypropyl)-3-((2,3-dihydroxypropyl)(methyl)carbamoyl)-5-((1-hydroxy-2-methoxyethylidene)amino)-2,4,6-triiodobenzene-1-carboximidic acid; N-(2,3-dihydroxypropyl)-3-[(2,3-dihydroxypropyl)(methyl)carbamoyl]-5-[(1-hydroxy-2-methoxyethylidene)amino]-2,4,6-triiodobenzene-1-carboximidic acid; RefChem:57670; V08AB05; 277-385-9; N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N1-methylisophthalamide; C18H24I3N3O8; 1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-3-N-methylbenzene-1,3-dicarboxamide; 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-((methoxyacetyl)amino)-N-methyl-; SHL 414C; Iopromidum [INN-Latin]; Iopromida [INN-Spanish]; EINECS 277-385-9; BRN 7085608; UNII-712BAC33MZ; Iopromide CRS; Iopromide [USAN:USP:INN:BAN]; Ultravist (TN); NCGC00016923-01; Proscope (TN); CAS-73334-07-3; Iopromide (Standard); BAY86-4877; BAY 86-4877; IOPROMIDE [INN]; IOPROMIDE [JAN]; IOPROMIDE [MI]; IOPROMIDE [USAN]; Prestwick0_000872; Prestwick1_000872; Prestwick2_000872; Prestwick3_000872; IOPROMIDE [VANDF]; IOPROMIDE [MART.]; IOPROMIDE [USP-RS]; IOPROMIDE [WHO-DD]; CHEMBL1725; Iopromide (JAN/USP/INN); SCHEMBL24546; BSPBio_000943; MLS002154045; Iopromide, analytical standard; SPBio_002864; BPBio1_001039; orb1308338; IOPROMIDE [EP IMPURITY]; IOPROMIDE [ORANGE BOOK]; IOPROMIDE [EP MONOGRAPH]; SCHEMBL29632300; HY-B1362R; IOPROMIDE [USP MONOGRAPH]; HMS1570P05; HMS2097P05; HMS2233O23; HMS3370M05; HMS3714P05; HMS5081F08; HY-B1362; MSK10801; Tox21_110684; AC-535; EBC-23637; s3207; AKOS025402129; Iopromid 100 |Ig/mL in Acetonitrile; Tox21_110684_1; CCG-220872; DB09156; FI35019; Iopromide for system suitability 1 CRS; Iopromide for system suitability 2 CRS; Iopromid 100 microg/mL in Acetonitrile; NCGC00179367-01; NCGC00179367-03; BS-17441; DA-64476; N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N1-methylbenzene-1,3-dicarboxamide; N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N3-methyl-benzene-1,3-dicarboxamide; SMR001233368; AB00513942; CS-0013103; NS00000230; A12801; D01893; EN300-19767813; SR-01000841262; Q4202805; SR-01000841262-2; BRD-A72075775-001-10-4; BRD-A72075775-001-11-2; Z2681890595; Iopromide, European Pharmacopoeia (EP) Reference Standard; Iopromide, United States Pharmacopeia (USP) Reference Standard; Iopromide for system suitability 1, European Pharmacopoeia (EP) Reference Standard; Iopromide for system suitability 2, European Pharmacopoeia (EP) Reference Standard; 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N1-methyl-; N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-5-{[(methyloxy)acetyl]amino}benzene-1,3-dicarboxamide; N~1~,N~3~-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N~1~-methylbenzene-1,3-dicarboxamideSynonyms